UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 11-K
                 ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

|X|      ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

                      For the year ended December 31, 2000

                                       OR

|_|      TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE
         SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED]

                         Commission File Number: 0-25544

                                 ---------------


A.   Full title of the plan and the address of the plan, if different  from that
     of the issuer named below:

       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan

B.   Name of the  issuer of the  securities  held  pursuant  to the plan and the
     address of its principal executive office:
C.

                          Miravant Medical Technologies
                336 Bollay Drive, Santa Barbara, California 93117

                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, Miravant
Medical Technologies as Plan Administrator has duly caused this annual report to
be signed on its behalf by the undersigned thereunto duly authorized.

                    Miravant   Medical   Technologies    401(k)-Employee   Stock
                    Ownership Plan

                                    By:  /s/  John M. Philpott
                                    --------------------------
                                              John M. Philpott
                                              Chief Financial Officer

Dated:   June 28, 2001







       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan




                                                                                                              

Financial Statements:
   Report of Independent Auditors.....................................................................................3
   Statements of Net Assets Available for Benefits as of December 31, 2000 and 1999...................................4
   Statements of Changes in Net Assets Available for Benefits for the years ended December 31, 2000, 1999 and 1998....5
   Notes to Financial Statements......................................................................................6

Supplemental Schedules:
   Schedule H, Line 4i - Schedule of Assets Held for Investment Purposes at End of Year..............................10
   Schedule H, Line 4j - Schedule of Reportable Transactions.........................................................11












                         Report of Independent Auditors


Plan Administrator
Miravant Medical Technologies
401(k)-Employee Stock Ownership Plan

We have audited the accompanying statements of net assets available for benefits
of the Miravant Medical Technologies  401(k)-Employee Stock Ownership Plan as of
December 31, 2000 and 1999 and the related  statements  of changes in net assets
available for benefits for each of the three years in the period ended  December
31,  2000.  These  financial  statements  are the  responsibility  of the Plan's
management.  Our  responsibility  is to express  an  opinion on these  financial
statements based on our audits.

We conducted our audits in accordance with auditing standards generally accepted
in the United States. Those standards require that we plan and perform the audit
to obtain reasonable  assurance about whether the financial  statements are free
of material misstatement. An audit includes examining, on a test basis, evidence
supporting  the amounts and  disclosures in the financial  statements.  An audit
also includes assessing the accounting principles used and significant estimates
made by  management,  as well as  evaluating  the  overall  financial  statement
presentation.  We believe  that our audits  provide a  reasonable  basis for our
opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material  respects,  the net assets  available  for benefits of the Miravant
Medical Technologies  401(k)-Employee  Stock Ownership Plan at December 31, 2000
and 1999,  and the changes in its net assets  available for benefits for each of
the three years in the period  ended  December  31,  2000,  in  conformity  with
accounting principles generally accepted in the United States.

Our audit was  performed  for the purpose of forming an opinion on the financial
statements taken as a whole. The accompanying  supplemental  schedules of assets
held  for  investment  purposes  at end of  year as of  December  31,  2000  and
reportable  transactions  for the year then ended, are presented for purposes of
additional analysis and are not a required part of the financial  statements but
are  supplementary  information  required by the Department of Labor's Rules and
Regulations for Reporting and Disclosure  under the Employee  Retirement  Income
Security Act of 1974. These supplemental schedules are the responsibility of the
Plan's  management.  The  supplemental  schedules  have  been  subjected  to the
auditing  procedures  applied in our audits of the financial  statements and, in
our  opinion,  are fairly  stated in all  material  respects  in relation to the
financial statements taken as a whole.

                                                     /s/ ERNST & YOUNG LLP


Woodland Hills, California
June 18, 2001






                          Miravant Medical Technologies
                      401(k)-Employee Stock Ownership Plan
                 Statements of Net Assets Available for Benefits




                                                                                           

                                                                                        December 31,
                                                                                 2000                  1999
                                                                           ------------------    ------------------
Assets:

   Employer contribution receivable..........................................    $    26,640          $      4,950
   Participant contribution receivable.......................................          4,930                 3,120
Investments, at fair value:
   Short-term investments....................................................          2,580                   190
   Miravant Medical Technologies common stock................................        234,090               167,960

                                                                           ------------------    ------------------

Total assets.................................................................        266,240               176,220


Net assets available for benefits............................................    $   266,240          $    176,220
                                                                           ==================    ==================



















See accompanying notes.





                          Miravant Medical Technologies
                      401(k)-Employee Stock Ownership Plan
           Statements of Changes in Net Assets Available for Benefits



                                                                                                


                                                                                 Year Ended December 31,
                                                                   2000                 1999                 1998
                                                             ------------------    ----------------     ---------------
Additions to net assets attributed to:
  Participant contributions.................................    $  86,470           $   67,820             $ 70,470
  Employer matching contributions...........................       87,100               34,030               35,060
  Investment income (loss):
    Interest income.........................................          120                   30                   30
    Net realized and unrealized depreciation in fair
     value of common stock investments......................      (60,740)              (9,450)             (37,510)
                                                             ------------------    ----------------     ---------------
Total additions.............................................      112,950               92,430               68,050

Deductions to net assets attributed to:
   Benefit payments to participants.........................       22,680               15,140                6,630
   Administrative expenses..................................          250                  160                  120
                                                             ------------------    ----------------     ---------------
Total deductions............................................       22,930               15,300                6,750
                                                             ------------------    ----------------     ---------------


Net increase................................................       90,020               77,130               61,300


Net assets available for benefits:

   Beginning of the year....................................      176,220               99,090               37,790
                                                             ------------------    ----------------     ---------------


   End of the year..........................................     $ 266,240           $ 176,220             $ 99,090
                                                             ==================    ================     ===============








See accompanying notes.





       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan
                          Notes to Financial Statements
                                December 31, 2000


1.   Plan Description

     The Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan (the
     "Plan") was  established to assist eligible  employees of Miravant  Medical
     Technologies  (the  "Company") to acquire and  accumulate  shares of common
     stock  of the  Company  through  payroll  deductions.  The  following  plan
     description provides only summary information;  reference should be made to
     the Plan document for more complete information.

     Substantially  all employees of the Company having at least three months of
     employment  with the Company (as defined in the Plan document) are eligible
     to participate in the Plan. The Plan provides that  participants  may elect
     to contribute from 1% to 6% of their  compensation up to the maximum limits
     permitted by the Internal  Revenue Code (the "Code").  The Code also places
     limits on the total  amount which can be added to any  employee's  accounts
     for a given year which apply in aggregate to all retirement plans sponsored
     by the Company.

     Under the provisions of the Plan, participant contributions are invested by
     the trustee in the  Company's  common  stock no later than the close of the
     third business day following the receipt of the participants' contributions
     from the Company. Upon receipt of the participant contributions,  but prior
     to the investment in the Company's  common stock, the funds are temporarily
     invested  by  the  trustee  in  short-term  investments  or  U.S.  Treasury
     obligations.

     Participants  in the  Plan  become  eligible  for a  discretionary  Company
     matching contribution  immediately upon enrolling in the Plan. All matching
     contributions  are invested in the Company's  common stock and the matching
     contribution  percentage  for each plan year is determined by the Company's
     Board of  Directors  prior to the  start of the Plan  year.  The  Company's
     matching  contributions  are made on a quarterly  basis,  and may be in the
     form of cash, shares of the Company's common stock, any other assets or any
     combination  thereof.  The employer's matching  contribution in the form of
     common stock is  determined  by using the closing  market price on the last
     business day of each quarter.  Matching cash  contributions are invested by
     the trustee in the  Company's  common stock within three  business  days of
     receipt of the cash contribution. For the year ended December 31, 2000, the
     Board of  Directors  directed  the  Company  to match  100% of the  amounts
     contributed by the participants.  For the years ended December 31, 1999 and
     1998,  the Board of  Directors  directed  the  Company  to match 50% of the
     amounts  contributed by the  participants.  The amounts  contributed by the
     Company  during 2000,  1999 and 1998 were made in the form of the Company's
     common stock and cash.

     Participants  become fully vested in the portion of the Company's  matching
     contributions  allocated  to their  accounts  if they are  employed  by the
     Company after a designated time period  according to the following  vesting
     schedule:

                           Years of Service               Vested Percentage
                           ----------------               -----------------
                           Less than 2 years                   0%
                           Two years                          10%
                           Three years                        30%
                           Four years                         60%
                           Five or more years                100%

     Additionally,  participants  become  fully  vested  in the  portion  of the
     Company's  matching  contributions  allocated to their accounts if they are
     employed by the Company  immediately  prior to retirement  (on or after the
     age of 59 1/2), permanent disability or death.

     If a participant leaves the Company prior to retirement, the portion of his
     or her matching account which is not vested will be forfeited.  Forfeitures
     are divided among the accounts of the remaining  participants in accordance
     with  specific  conditions  defined in the Plan.  The Plan also  contains a
     rehire and reinstatement  provision, for which the terms and conditions are
     defined  in the Plan.  The  forfeitures  reallocated  for the  years  ended
     December 31, 2000 and 1999 were $2,094 and $4,046, respectively.

     Common stock,  plus cash for any partial share credited to a  participant's
     account,   will  be  generally  distributed  to  the  participant  (or  the
     participant's  designated  beneficiary  or estate) in full,  within certain
     limitations  and  restrictions  as provided in the Plan document,  no later
     than 60 days  after the end of the Plan  year  during  which a  participant
     becomes  eligible for a distribution  due to permanent  disability,  death,
     retirement  or  termination   of   employment.   Prior  to  termination  of
     employment,  shares can be distributed to a participant  upon attaining age
     59 1/2 while still an employee or for  emergencies at the discretion of the
     Plan Administrator, as provided in the Plan document.

     The Plan's assets, which consist principally of the Company's common stock,
     are held in safekeeping for custodial  purposes by an independent  trustee.
     Contributions  are managed by the trustee,  which invests cash received and
     interest,  and makes distributions to participants.  Certain administrative
     functions  are  performed by officers or employees of the Company.  No such
     officer or employee receives compensation from the Plan.

     The Company  currently  expects to continue  the Plan  indefinitely  and to
     continue  to make  contributions  under  the  Plan.  However,  there  is no
     contractual  commitment  requiring  the  Company to  continue to make these
     contributions  to the Plan. The Company's  Board of Directors has the right
     to alter or terminate  the Plan at any time and for any reason,  subject to
     the  provisions  of the  Employee  Retirement  Income  Security Act of 1974
     ("ERISA").  In the event of Plan termination,  participants will become 100
     percent vested in their accounts.

2.   Summary of Significant Accounting Policies

     Basis of Accounting

     The accompanying  financial statements are prepared on the accrual basis of
     accounting.

     Estimates and Assumptions

     The  preparation  of financial  statements  in  conformity  with  generally
     accepted  accounting  principles  requires management to make estimates and
     assumptions  that affect the amounts  reported in the financial  statements
     and  the  accompanying  notes.  Actual  results  could  differ  from  those
     estimates and such differences may be material to the financial statements.

     Participant Contributions

     Contributions  are recorded when the Company makes payroll  deductions from
     the Plan participants.

     Participant Withdrawals

     Participant  withdrawals and payments made to terminated  participants  are
     recorded on the date distributions are made.

     Stock Purchases

     Stock  purchases  are made by the Plan's  trustee by the close of the third
     business  day  following  receipt  of  the  participant  or  cash  matching
     contributions from the Company.

     Investment Valuation

     The Plan's  investments are stated at fair value.  The closing market share
     price,  which  was  $9.28  and  $9.31 as of  December  31,  2000 and  1999,
     respectively, were used to value shares of the Company's common stock.

     Plan Expenses

     Substantially all of the plan expenses are paid for by the Company.

3.   Income Tax Status

     The Plan received a determination  letter from the Internal Revenue Service
     dated  September  15, 1999,  stating that the Plan is  qualified,  in form,
     under  Section  401(a) of the Code and,  therefore,  the  related  trust is
     exempt from taxation.  Once  qualified,  the Plan is required to operate in
     conformity  with  the  Code  to  maintain  its   qualification.   The  Plan
     Administrator  believes the Plan is being  operated in compliance  with the
     applicable requirements of the Code and, therefore,  believes that the Plan
     qualifies and the related trust is tax exempt.  Subsequent  amendments have
     been  structured to, and are intended to, maintain the Plan's tax qualified
     status.

4.   Administrative Expenses

     Certain administrative  functions are performed by officers or employees of
     the Company.  No officer or employee  receives  compensation from the Plan.
     Substantially all expenses associated with the establishment, operation and
     administration of the Plan are paid by the Company.

5.   Party-In-Interest Transactions

     The Company and the trustee  are  parties-in-interest  with  respect to the
     Plan under the  provisions  of ERISA.  The records of the Plan  indicate no
     party-in-interest  transactions  which are  prohibited by ERISA Section 406
     and for which no statutory or administrative exemption exists.

6.   Differences Between Financial Statements and Form 5500

     The  Form  5500  does  not  reflect  amounts  contributed  to the  Plan  by
     participants  or by the employer for the final pay period of each year as a
     result of timing of payroll. As such, the financial  statements differ from
     participant  contributions  per the Form 5500 as of  December  31, 2000 and
     1999 and for the years then ended by $4,930 and $1,465, respectively. There
     was no such difference  related to participant  contributions  for the Plan
     year ended December 31, 1998. In addition, financial statements differ from
     employer  contributions  per the Form 5500 as of December  31, 2000 and for
     the year then ended by $4,930.  There were no such  differences  related to
     employer contributions for the Plan years ended December 31, 1999 and 1998.
     Additionally,  amounts allocated to withdrawn  participants are recorded on
     the Form 5500 for benefit  claims that have been processed and approved for
     payment prior to year end but not yet paid. As such,  benefits paid per the
     financial  statements differ from benefits paid per the Form 5500 by $3,930
     and $4,170 for the years ended  December  31, 1999 and 1998,  respectively,
     due to the amounts allocated to withdrawn participants.  There were no such
     differences  related to benefit  payments for the plan year ended  December
     31, 2000.









                                                                                                


       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan
 Schedule H, Line 4i - Schedule of Assets Held for Investment Purposes at End of Year*
                                December 31, 2000


                                                                                                  Current Value
            Identity of Issue              Description of Asset                      Cost
- ------------------------------------------ ------------------------------------ ---------------- -----------------
  Miravant Medical Technologies Common
                 Stock**                              25,222 shares               $     347,380     $     234,090

     Arrowhead Trust Incorporated**              Short-term investments           $       2,580     $       2,580



*    Under ERISA, an asset held for investment purposes is any asset held by the
     Plan on the last day of the  Plan's  fiscal  year or  acquired  at any time
     during the Plan's  fiscal year and  disposed of at any time before the last
     day of the Plan's fiscal year, with certain exceptions.

**   Party-In-Interest








                                                                                              



       Miravant Medical Technologies 401(k)-Employee Stock Ownership Plan
           Schedule H, Line 4j - Schedule of Reportable Transactions*
                          Year Ended December 31, 2000


                                                                                              Current Value of
   Identity of Party                                    Purchase     Selling     Cost of          Asset on      Net Gain/(Loss)
       Involved             Description of Asset          Price        Price       Asset      Transaction Date
- ------------------------ ---------------------------- -------------- ----------- ----------- ------------------ --------------

    Miravant Medical
    Technologies**       Common Stock                        $7,680        --      $  7,680           $  7,680             --
                                                                 --  $ 12,260      $ 12,260           $ 12,260        $ 4,580


    Arrowhead Trust      Short-term investments
    Incorporated**                                         $ 59,400          --    $ 59,400           $ 59,400             --
                                                                 --    $ 59,530    $ 59,530           $ 59,530           $130


    Sanwa Bank**          Short-term investments           $ 37,110         --    $ 37,110            $ 37,110             --
                                                                 --   $ 37,110    $ 37,110            $ 37,110             --



*    Transactions  in excess of five percent of the current  value of the Plan's
     assets as of  January  1, 2000 as  defined  in  Section  2520.103-6  of the
     Department of Labor's Rules and  Regulations  for Reporting and  Disclosure
     under ERISA.

**   Party-In-Interest







                                INDEX TO EXHIBITS

Exhibit                                                  Incorporating Reference
Number                Description                          (If Applicable)
- ------                -----------                          ---------------

23.1                  Consent of Independent Auditors











                                  EXHIBIT 23.1
                         CONSENT OF INDEPENDENT AUDITORS

     We consent to the incorporation by reference in the Registration  Statement
     (Form S-8 No.  333-34953)  pertaining to the Miravant Medical  Technologies
     401(k)-Employee  Stock  Ownership  Plan of our report  dated June 18, 2001,
     with  respect to the  financial  statements  and  schedules of the Miravant
     Medical Technologies  401(k)-Employee Stock Ownership Plan included in this
     Annual Report (Form 11-K) for the year ended December 31, 2000.


                                      /s/  ERNST & YOUNG LLP




Woodland Hills, California
June 27, 2001